Kira Biotech

Business Services · Australia · 1-10 Employees

View Company Info for Free

Overview

Headquarters

315 Brunswick St L 2, Fortitude Valley, ...

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Kira Biotech

Kira Biotech is an emerging Australian biotech company focused on the development of novel immunomodulatory drugs for the treatment of immune system disorders. The company aims to advance immunology drug development through strategic business and corporate development activities, particularly in the United States. With a team of experienced professionals from the pharmaceutical industry, Kira Biotech is dedicated to bringing innovative therapies to patients. Their target clients include healthcare organizations and pharmaceutical companies seeking advanced solutions in immunology.Explore more
Kira Biotech's Social MediaPopular SearchesKira Biotech Pty LtdSIC Code 87,873NAICS Code 54,541Show more

Kira Biotech Org Chart

Daniel Baker, Chief Executive Officer at Kira Biotech
Australia flag for contact location.

Chief Executive Officer

PhoneEmail
JU
Australia flag for contact location.

Chief Business Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
AT
Australia flag for contact location.

Project Manager, CMC & Clinical

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Kira Biotech your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Kira Biotech

Compare insights from companies similar to Kira Biotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Kira Biotech

<$5M
1-10
Private
$20M
2019
$6.5M
11-50
Private
-
-
MW
Mike WestChief Operating Officer
<$5M
11-50
Private
-
2016
LJ
Lubomira JamriskaDirector, Biotherapeutics
<$5M
11-50
Private
-
2014
CE
Christopher ElliotChief Financial Officer & Company Secretary
<$5M
11-50
Private
-
2019
LC
Larisa ChisholmChief Operating Officer
<$5M
1-10
Private
-
2017
WM
Wim MeutermansChief Scientific Officer
<$5M
1-10
Private
-
2017
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Kira Biotech is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Kira Biotech is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Kira Biotech.

Kira Biotech financials insights

Gather financial insights about Kira Biotech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2019

Series A

$20M

See All Kira Biotech's Financials Insights

Kira Biotech Tech Stack

A closer look at the technologies used by Kira Biotech

Kira Biotech News & Media

  • KiRA Biotech Appoints Global Pharma Business Leader as Independent Board Chair

    BRISBANE, Australia--(BUSINESS WIRE)--Australian drug development company Kira Biotech, with a mission to bring new treatment options to patients with autoimmune and inflammatory conditions, has announced the appointment of Michael Grissinger as independent Chair of its Board of Directors. Michael has had a highly successful career in senior business and corporate development roles within global pharmaceutical companies. He spent 22 years at Johnson &amp; Johnson, holding positions of Vice Pres
Read more news

Top Business Services Companies

Frequently Asked Questions Regarding Kira Biotech

What is Kira Biotech's official website?
Kira Biotech's official website is www.kirabiotech.com
What is Kira Biotech's Revenue?
Kira Biotech's revenue is <$5 Million
What is Kira Biotech's SIC code?
Kira Biotech's SIC: 87,873
What is Kira Biotech's NAICS code?
Kira Biotech's NAICS: 54,541
How many employees does Kira Biotech have?
Kira Biotech has 1-10 employees
What industry does Kira Biotech belong to?
Kira Biotech is in the industry of: Business Services, Research & Development
What is Kira Biotech competition?
Kira Biotech top competitors include: BioCurate, Anaxis Pharma, Vast Bioscience, Salut Products
What technology does Kira Biotech use?
Some of the popular technologies that Kira Biotech uses are: WooCommerce, WordPress.org, PHP, Sucuri WAF
What does Kira Biotech do?

Kira Biotech is an emerging Australian biotech company focused on the development of novel immunomodulatory drugs for the treatment of immune system disorders. The company aims to advance immunology drug development through strategic business and corporate development activities, particularly in the United States. With a team of experienced profess... ionals from the pharmaceutical industry, Kira Biotech is dedicated to bringing innovative therapies to patients. Their target clients include healthcare organizations and pharmaceutical companies seeking advanced solutions in immunology.Read More

What are Kira Biotech social media links?
Kira Biotech Linkedin page
Who invested in Kira Biotech?
Kira Biotech has 3 investors including IP Group, OneVentures and Advance Queensland Business Development Fund.
Is Kira Biotech a public company?
Kira Biotech is private company therefore does not currently have an official ticker symbol
See more information about Kira Biotech

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.